That remains to be seen; however, companies other than MNTA have not, to my knowledge, conducted the kinds of switching studies mandated by the FDA's draft guidance on interchangeable FoBs (#msg-127945401).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”